arrow
M

Marjon V. Verschueren

St. Antonius Hospital
H指数:6
被引数:181

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Checkpoint inhibitor effectiveness after corticosteroids and second-line immunosuppressants for immune-related adverse events in non-small-cell lung cancer

糖皮质激素和二线免疫抑制剂对非小细胞肺癌免疫相关不良事件后检查点抑制剂的有效性

2026-01-200
OAAI
Real world effectiveness of durvalumab in stage III unresectable non-small cell lung cancer: what is the role of PD-L1 expression?

III期不可切除非小细胞肺癌 durvalumab 的真实世界有效性:PD-L1 表达的作用是什么?

2025-07-170
OAAI
Exploring the impact of patient-specific clinical features on osimertinib effectiveness in a real-world cohort of patients with EGFR mutated non-small cell lung cancer
2023-10-156
OA